Carolyn M. Tastad - Mar 1, 2022 Form 4 Insider Report for PROCTER & GAMBLE Co (PG)

Role
CEO - Health Care
Signature
/s/ Aaron B. Shepherd, attorney-in-fact for Carolyn M. Tastad
Stock symbol
PG
Transactions as of
Mar 1, 2022
Transactions value $
-$572,597
Form type
4
Date filed
3/3/2022, 08:54 AM
Previous filing
Feb 11, 2022
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PG Common Stock Sale -$573K -3.73K -11.7% $153.51 28.2K Mar 1, 2022 Direct F1, F2
holding PG Common Stock 5.89K Mar 1, 2022 By Retirement Plan Trustee F3
holding PG Common Stock 1.99K Mar 1, 2022 By Spouse
holding PG Common Stock 668 Mar 1, 2022 By Spouse, By Retirement Plan Trustees F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PG Restricted Stock Units Award $0 +38.8 +6.26% $0.00 659 Feb 15, 2022 Common Stock 38.8 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.
F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F3 Reflects adjustment to PST through December 31, 2021.
F4 Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F5 These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.